Indeed, the impact of IFN-α itself might be enough to control the viral load at the beginning of the viral infection and thus preclude the subsequent severe course of COVID-19 disease, while resembling a physiological endogenous response to viral infections and avoiding side effects of synthetic antivirals (95, 96). This evidence concerns the gene IFNA2 and COVID-19.